ID
33300
Descripción
Study ID: 106837 Clinical Study ID: HZA106837 Study Title: A Long-Term, Randomized, Double-Blind, Parallel Group Study of Fluticasone Furoate/GW642444 Inhalation Powder Once-Daily and Fluticasone Furoate Inhalation Powder Once-Daily in Subjects with Asthma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01086384 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone furoate/vilanterol Trade Name: Relvar Study Indication: Asthma
Palabras clave
Versiones (2)
- 5/11/18 5/11/18 -
- 4/12/18 4/12/18 -
Titular de derechos de autor
GSK group of companies
Subido en
4 de diciembre de 2018
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
A Parallel Group Study of Fluticasone Furoate/Vilanterol in Subjects with Asthma - 106837
Pharmacogenetic Research Consent
- StudyEvent: ODM
Descripción
Sample Type
Alias
- UMLS CUI-1
- C2347029
Similar models
Pharmacogenetic Research Consent
- StudyEvent: ODM
C0035168 (UMLS CUI-2)
C1511481 (UMLS CUI-3)
C0200345 (UMLS CUI-4)
C0031325 (UMLS CUI [2,1])
C0035168 (UMLS CUI [2,2])
C0031325 (UMLS CUI [2,1])
C0035168 (UMLS CUI [2,2])
C1882120 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
C1882120 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
C2348235 (UMLS CUI [1,5])
C0031325 (UMLS CUI [2,1])
C0035168 (UMLS CUI [2,2])
Sin comentarios